Shared Individual Formulation Therapy (SIFT): an open-label trial of a new therapy accommodating patient heterogeneity in functional neurological disorder

ConclusionThis trial provides preliminary evidence for initial and sustained benefit from SIFT for adults with FND. Further study is needed to validate these findings.

http://link.springer.com/10.1007/s00415-021-10797-y

Source: Journal of Neurology - September 19, 2021 Category: Neurology Source Type: research